170 related articles for article (PubMed ID: 6602848)
1. Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells.
Luger TA; Charon JA; Colot M; Micksche M; Oppenheim JJ
J Immunol; 1983 Aug; 131(2):816-20. PubMed ID: 6602848
[TBL] [Abstract][Full Text] [Related]
2. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
[TBL] [Abstract][Full Text] [Related]
3. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
Luger TA; Uchida A; Köck A; Colot M; Micksche M
J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
[TBL] [Abstract][Full Text] [Related]
4. Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis.
Sauder DN; Mounessa NL; Katz SI; Dinarello CA; Gallin JI
J Immunol; 1984 Feb; 132(2):828-32. PubMed ID: 6361134
[TBL] [Abstract][Full Text] [Related]
5. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
Luger TA; Stadler BM; Luger BM; Mathieson BJ; Mage M; Schmidt JA; Oppenheim JJ
J Immunol; 1982 May; 128(5):2147-52. PubMed ID: 6801132
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
Yoshimura T; Matsushima K; Oppenheim JJ; Leonard EJ
J Immunol; 1987 Aug; 139(3):788-93. PubMed ID: 3298433
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line.
Luger TA; Stadler BM; Luger BM; Sztein MB; Schmidt JA; Hawley-Nelson P; Grabner G; Oppenheim JJ
J Invest Dermatol; 1983 Sep; 81(3):187-93. PubMed ID: 6604110
[TBL] [Abstract][Full Text] [Related]
8. Biologic properties of epidermal cell thymocyte-activating factor (ETAF).
Sauder DN
J Invest Dermatol; 1985 Jul; 85(1 Suppl):176s-179s. PubMed ID: 3874245
[TBL] [Abstract][Full Text] [Related]
9. Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).
Luger TA; Stadler BM; Katz SI; Oppenheim JJ
J Immunol; 1981 Oct; 127(4):1493-8. PubMed ID: 6974195
[TBL] [Abstract][Full Text] [Related]
10. Studies on the molecular nature of human interleukin 1.
Auron PE; Warner SJ; Webb AC; Cannon JG; Bernheim HA; McAdam KJ; Rosenwasser LJ; LoPreste G; Mucci SF; Dinarello CA
J Immunol; 1987 Mar; 138(5):1447-56. PubMed ID: 3492551
[TBL] [Abstract][Full Text] [Related]
11. Epidermal cells synthesize a cytokine with interleukin 3-like properties.
Luger TA; Wirth U; Köck A
J Immunol; 1985 Feb; 134(2):915-9. PubMed ID: 3917479
[TBL] [Abstract][Full Text] [Related]
12. Normal human neutrophils are a source of a specific interleukin 1 inhibitor.
Tiku K; Tiku ML; Liu S; Skosey JL
J Immunol; 1986 May; 136(10):3686-92. PubMed ID: 3486218
[TBL] [Abstract][Full Text] [Related]
13. Biologic properties of the thymocyte-activating factor (CETAF) produced by a rabbit corneal cell line (SIRC).
Grabner G; Luger TA; Luger BM; Smolin G; Oh JO
Invest Ophthalmol Vis Sci; 1983 May; 24(5):589-95. PubMed ID: 6841006
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between structure and function of a chemotactic factor for human leukocytes].
Carletti R; Spisani S; Traniello S
Boll Soc Ital Biol Sper; 1981 Nov; 57(22):2257-63. PubMed ID: 7326113
[TBL] [Abstract][Full Text] [Related]
15. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
Goetzl EJ; Rocklin RE
J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
[TBL] [Abstract][Full Text] [Related]
16. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
17. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.
Gahring LC; Buckley A; Daynes RA
J Clin Invest; 1985 Oct; 76(4):1585-91. PubMed ID: 2997285
[TBL] [Abstract][Full Text] [Related]
18. Macrophage inflammatory protein-1 alpha expression in interstitial lung disease.
Standiford TJ; Rolfe MW; Kunkel SL; Lynch JP; Burdick MD; Gilbert AR; Orringer MB; Whyte RI; Strieter RM
J Immunol; 1993 Sep; 151(5):2852-63. PubMed ID: 8360496
[TBL] [Abstract][Full Text] [Related]
19. Epidermal cell thymocyte activity factor/interleukin 1 (ETAF/IL)-like activity in lymph drained from normal human skin.
Olszewski WL; Grzelak I; Ziolkowska A; Engeset A
Lymphology; 1988 Jun; 21(2):118-23. PubMed ID: 3265464
[TBL] [Abstract][Full Text] [Related]
20. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.
Schröder JM; Mrowietz U; Morita E; Christophers E
J Immunol; 1987 Nov; 139(10):3474-83. PubMed ID: 2824608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
